MyChesCo on MSN1d
Carpenter Technology Appoints Julie A. Beck to Board of Directors
PHILADELPHIA, PA — Carpenter Technology Corporation (NYSE: CRS) has announced the appointment of Julie A. Beck to its Board of Directors, effective February 20, 2025. The addition of Ms. Beck expands ...
BP’s CEO Cut His Teeth on Crisis — Now He Faces the Toughest Test Yet
“Boy, his hat is crises!” said Bob Dudley, former BP CEO and a mentor to Auchincloss. “I always said to Murray: management ...
IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire
IDEX Corporation (NYSE: IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the ...
BP weighs sale of Castrol lubricant unit
BP Plc, in which activist investor Elliott Investment Management has built up a nearly 5% stake, is considering a potential ...
America’s biggest oil producers adjust to a new reality in the Gulf of Whatever
Oil giants are falling in line to adopt the U.S. President’s contentious renaming of the home to major offshore oil and gas ...
BP weighs potential sale of Castrol Lubricants unit amid Elliott push
A sale of the business is one of the many options BP is considering to win back investor confidence after years of under ...
EuropaWire4d
Lightsource bp Secures 10 Power Purchase Agreements in 2024, Expanding Global Renewable Energy Reach
In 2024, Lightsource bp secured 10 power purchase agreements (PPAs) totaling 1.3GW across Europe, the Americas, and APAC, highlighting its strong ...
BP Weighs Sale of Castrol Lubricants Unit Amid Elliott Push
BP Plc, in which activist investor Elliott Investment Management has built up a nearly 5% stake, is considering a potential ...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
manilatimes5d
Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook
Secured three additional regulatory approvals for world's first chikungunya vaccine, IXCHIQ ® (Canada, Europe, UK); filed adolescent label extension submissions; awarded new $41.3 million grant from ...